AG NPP709 is presently available; on the other hand, no review has investigated the impact of AG NPP709 in patients with COPD. Thus, the goal of the examine was to evaluate the efficacy of AG NPP709 in people with Continual bronchitis kind COPD.Berberine suppresses inflammatory brokers-induced interleukin-1beta and tumor necrosis issue-alpha produc